Page 48 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By TVN Staff | April 15, 2021 | 9:26 a.m. ET. Telstra has appointed Kris Schaffer Canada country lead to drive accelerated growth out of the Toronto area. An IT and telecom professional, he has filled both leadership and customer-facing roles at IBM, Bell Canada and TELUS Communications. In addition, Karl Paterson, a sales executive with more than 10 years of telco and technology industry experience has been brought onboard as a business development executive, reporting directly to Schaffer. Telstra Americas recently opened a new office in Toronto and upgraded infrastructure to connect Canad...

One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg reports Ginkgo Bioworks is in talks with Soaring Eagle Acquisition Corp (NASDAQ: SRNGU), a SPAC led by Harry Sloan and... Read More...

04.09.21 -- Listen Now: Antiviral Conjugates, Peptides, Biopharma Funding Success     The Business of Biotech, Biotech with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters including our podcast series. Don’t forget to subscribe so you never miss an episode!       Life sciences CFO extraordinaire Allan Shaw shares incremental steps to biopharma success and dishes on the mistakes he's seen in his many engagements with new and emerging biotech firms. From capital resource allocation t...

04.08.21 -- Listen Now: Antiviral Conjugates, Peptides, Biopharma Funding Success     The Business of Biotech, Biotech with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters including our podcast series. Don’t forget to subscribe so you never miss an episode!       Life sciences CFO extraordinaire Allan Shaw shares incremental steps to biopharma success and dishes on the mistakes he's seen in his many engagements with new and emerging biotech firms. From capital resource allocation t...

share: This news release, issued by Johns Hopkins Medicine, describes a novel targeted immunotherapy approach. This new approach employs bispecific antibodies to treat cancer by eliciting a Tcell response against mutated p53. The researchers used the Highly Automated Macromolecular Crystallography (AMX) and Frontier Microfocusing Macromolecular Crystallography (FMX) beamlines to characterize the molecular structure of the proteins. AMX and FMX are beamlines at the National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science User Facility at Broo...